A detailed history of Covestor LTD transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Covestor LTD holds 5 shares of AGIO stock, worth $278. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 12 58.33%
Holding current value
$278
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$41.19 - $49.72 $288 - $348
-7 Reduced 58.33%
5 $0
Q2 2024

Aug 09, 2024

BUY
$27.55 - $48.83 $220 - $390
8 Added 200.0%
12 $1,000
Q1 2024

May 10, 2024

SELL
$21.32 - $34.81 $149 - $243
-7 Reduced 63.64%
4 $0
Q4 2023

Feb 09, 2024

BUY
$19.97 - $24.53 $39 - $49
2 Added 22.22%
11 $0
Q3 2023

Nov 13, 2023

BUY
$24.36 - $28.18 $97 - $112
4 Added 80.0%
9 $0
Q4 2022

Feb 13, 2023

SELL
$24.81 - $31.52 $49 - $63
-2 Reduced 28.57%
5 $0
Q3 2022

Nov 14, 2022

BUY
$19.51 - $34.14 $136 - $238
7 New
7 $0

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.05B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.